Dermatology.
Northgate represents dermatologists across medical, Mohs and procedural, dermatopathology, pediatric, and cosmetic disciplines.
Your career in dermatology.
Dermatology has been reshaped by capital in ways most specialties have not. A senior partner inside a PE-backed platform asking about the next earnout is in a different conversation than a junior partner in an independent group deciding whether to sell. A Mohs surgeon evaluating an academic appointment is in a different conversation than a cosmetic-only dermatologist running a cash-pay practice. We treat the practice model as the unit of the conversation, not the line on the certificate.
The work within dermatology.
We are deliberate about the sub-discipline and the practice model behind it. The market for a Mohs surgeon coming out of a fellowship is not the market for a senior medical dermatologist leaving a consolidator after the second earnout. The sub-disciplines below guide our approach to dermatology representation.
- Medical Dermatology
- General medical and immunodermatology, biologics-heavy practice, complex medical referral. Productivity model and biologic-infusion economics often drive the conversation.
- Mohs & Procedural
- Mohs micrographic surgery and complex reconstruction. A small universe; fellowship-trained Mohs surgeons command the highest comp in dermatology and the most disciplined offer construction.
- Dermatopathology
- Slide-reading volume, sign-out economics, and laboratory affiliation define most senior moves. Often a path to lab medical directorship.
- Pediatric Dermatology
- Almost exclusively children’s hospital and academic. A small senior pool; the negotiation tends to be about protected academic time more than headline base.
- Cosmetic & Aesthetic
- Energy devices, injectables, and procedural cosmetics. Independent cash-pay practices and PE-backed med-spa platforms are two very different conversations.
The dermatologist we represent.
We are most useful to dermatologists who are seven to twenty years into practice, board-certified, and at a real inflection point. A buy-in decision in a group that is preparing for a sale. A second earnout that is materializing or evaporating. A non-compete running out. An academic appointment opening at a department you have followed for years. A move out of a consolidator and back to independence.
The conversation tends to work less well for trainees, for physicians early in a private practice ramp, and for engagements where the platform refuses to discuss productivity bonus structure or restrictive covenants up front.
- Tenure
- Seven to twenty years post-residency or fellowship, with at least three years at the current practice. Earlier-career dermatologists better served by their training network.
- Procedural training
- Fellowship-trained Mohs, dermatopathology, or pediatric. For cosmetic-heavy moves, depth and breadth of device and injectable experience.
- Practice-model preference
- Independent partnership, PE-backed platform, academic appointment, or cash-pay cosmetic. The four are not interchangeable. We ask early.
- Restrictive covenant posture
- Whether you are inside a non-compete, when it expires, and whether you have negotiated geographic limits. This shapes the engagement list.
- Reason for the conversation
- A specific reason this season, not general curiosity. The reason itself usually shapes the right next role.
The rooms we work in.
The settings we consider for dermatology career opportunities.
- Academic Medical Centers
- Independent Dermatology Groups
- PE-Backed Dermatology Platforms
- Children’s Hospitals
- Dermatopathology Laboratories
- Multi-specialty Groups
- Cosmetic / Aesthetic Practices
- Faculty Practice Plans
